Indigenous Australians experience a disproportionately high burden of alcohol-related harm relative to non-Indigenous Australians. These alcohol-related harms are typically cumulative, extending beyond the individual to the family and community.
Treatment and Intervention
Socioeconomically disadvantaged groups are more likely to smoke than other sectors of the community. This difference has been attributed, in part, to increased rates of relapse. Relapse is strongly and consistently predicted by financial stress.
The project aims to investigate the opinions of young Australians about how the government and community should respond towards drug and alcohol use.
Researchers, health professionals, consumer groups and advocates in the field have repeatedly called for widespread availability of naloxone for people who inject drugs and potential overdose witnesses, to reduce the incidence of fatal overdose.
Heroin use and associated harms can be reduced through effective treatment. Past research has shown that treatment for heroin dependence can be relatively cost-effective, but not whether heroin treatment overall is a good investment.
Drug dependence is a chronic relapsing condition, associated with high levels of psychopathology.
Limited research suggests a strong association between adult Attention Deficit Hyperactivity Disorder (ADHD) and substance use disorders (SUD), with adult ADHD over-represented among people with substance use problems (20-40% prevalence).
There has been a recent increase in the prescribing of pharmaceutical opioids to Chronic Non-Cancer Pain (CNCP) patients in Australia which has led to increasing professional and public concern about the use and harms that may be related to such use.
NIDIP was established in the recognition that there was a greater need for the regular dissemination of trends in the epidemiology of drug-related harms in Australia.